Research Article of American Journal of Dermatological Research and Reviews
Single Oral Dose of Ivermectin as a New Therapeutic Trial for Contacts of Patients with Scabies
Khalifa E. Sharquie1, Adil A. Noaimi2, Riyam A. Flayyih3
1Professor, MD, PhD, FRCP Edin, Department of Dermatology, College of Medicine, University of Baghdad. Iraqi and Arab Board for Dermatology and Venereology, Baghdad Teaching Hospital, Medical City, Baghdad, Iraq. 2Professor, MD, DDV, FICMS, Department of Dermatology, College of Medicine, University of Baghdad. Iraqi and Arab Board for Dermatology and Venereology, Baghdad Teaching Hospital, Medical City, Baghdad, Iraq. 3MD, Center of Dermatology; Baghdad Teaching Hospital; Medical City, Baghdad, Iraq.
Background: Scabies is one of the common epidemic and endemic diseases worldwide. Many topical therapeutic modalities for scabies are available. Topical ivermectin has been used effectively in treatment of scabies but there is no oral effective therapy that prevents contacts to get scabies.
Objective: To evaluate the effectiveness of oral ivermectin in prevention of scabies contacts to get scabies.
Patients and Methods: The study is a single-blinded therapeutic study that was conducted in the Center of Dermatology, Baghdad Teaching Hospital, Baghdad, Iraq during the period from April 2018 through October 2019.Two hundred sixty healthy scabies contacts were included in this study, their ages ranged from 5-60 years with a mean ± SD of 19.3± 1.9 years. All these contacts were screened for active scabies and they were all free. The contacts of scabies were treated by ivermectin tablet 200 microgram per kg as a single dose after 2 hours from dinner. They were seen regularly after 4 weeks to be re-examined and to record any scabies and drug side effects.
Results: The response after four weeks of single dose therapy of healthy contacts showed that 245 (94%) from 260 were free of scabies and only 15(6%) contacts showed infection with scabies and this was statistically significant Chi-square (c2= 148, P-value less than 0.00000001. No any side effects were noticed in any treated contacts.
Conclusion: Oral single ivermectin dose is an effective therapy to prevent scabies contacts to get infection. It an easy method of prevention which is very useful in condition of scabies outbreaks and epidemics to stop the rapid spread of the disease.
Keywords: scabies, oral ivermectin, single dose, contacts.
How to cite this article:
Khalifa E. Sharquie, Adil A. Noaimi, Riyam A. Flayyih. Single Oral Dose of Ivermectin as a New Therapeutic Trial for Contacts of Patients with Scabies. American Journal of Dermatological Research and Reviews, 2020, 3:26. DOI: 10.28933/ajodrr-2020-04-1805
1. Currier RW, Walton SF, Currie BJ. Scabies in animals and humans: history, evolutionary perspectives, and modern clinical management. Annals of the New York Academy of Sciences. 2011 Aug; 1230(1):E50-60.
2. Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Andrews R, Kaldor JM, Steer AC. Mass drug administration for scabies control in a population with endemic disease. New England Journal of Medicine. 2015 Dec 10; 373(24):2305-13.
3. Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. New England Journal of Medicine. 2010 Feb 25; 362(8):717-25.
4. Al-Rawi J R. Clinic-epidemiological study of scabies in Baghdad Teaching Hospital (Master Thesis in Community Medicine, College of Medicine, Al-Mustansirya University), 1990.
5. Al-Badri A A. Epidemiological and therapeutic study of scabies in Baghdad (Master thesis in Community Medicine, College of Medicine University of Baghdad), 1994.
6. Chosidow O. Scabies. New England Journal of Medicine. 2006 Apr 20; 354(16):1718-27.
7. Scott GR, Chosidow O; IUSTI/WHO. European guideline for the management of scabies, 2010.Int J STD AIDS. 2011 Jun; 22(6):301-3.
8. Meinking T, Burkhart CG, Burkhart CG, James R. Ectoparasitic diseases in dermatology: reassessment of scabies and pediculosis, pp. 77–108. Advances in dermatology, vol. 15. 1999.
9. Meinking TL, Taplin D, Herminda JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. New England Journal of Medicine. 1995 Jul 6; 333(1):26-30.
10. Workowski KA, Bolan GA. sexually transmitted diseases treatment guidelines, 2015. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports. 2015 Jun 5; 64(RR-03):1.
11. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. The Lancet. 1997; 349(9059):1144-5.
12. Marks M, Taotao-Wini B, Satorara L, Engelman D, Nasi T, Mabey DC, Steer AC. Long term control of scabies fifteen years after an intensive treatment programme. PLoS neglected tropical diseases. 2015 Dec; 9(12).
13. Usha V, Nair TG. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. Journal of the American Academy of Dermatology. 2000 Feb 1; 42(2):236-40.
14. Roos TC, Roos S, Merk HF, Bickers DR. Pharmacotherapy of ectoparasitic infections. Drugs. 2001 Jul 1; 61(8):1067-88.
15. Fuller LC. Epidemiology of scabies. Current opinion in infectious diseases. 2013 Apr 1; 26(2):123-6.
16. Ribeiro FD, Taciro E, Guerra MR, Eckley CA. Oral ivermectin for the treatment and prophylaxis of scabies in prison. Journal of dermatological treatment.2005Jan1; 16(3):138-41.
This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.